Skip to content

Feasibility and Safety of Spontaneous-Breathing Oliceridine–Propofol Intravenous Anesthesia for Ureteroscopic Holmium Laser Lithotripsy

Feasibility and Safety of Spontaneous-Breathing Oliceridine–Propofol Intravenous Anesthesia for Ureteroscopic Holmium Laser Lithotripsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117738
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-01-28
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract stones

Interventions

Intervention group:Spontaneous-breathing oliceridine–propofol intravenous anesthesia under a laryngeal mask

Sponsors

Cixi People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–65 years, either sex; 2. ASA physical status I–II; 3. Scheduled for elective ureteroscopic holmium laser lithotripsy; 4. BMI 18–30 kg/m²; 5. Has signed informed consent and is able to comply with 24-hour postoperative follow-up.

Exclusion criteria

Exclusion criteria: 1. Use of psychotropic drugs or presence of psychiatric disorders; 2. Refusal to provide consent for participation; 3. Severe cardiopulmonary disease; 4. Severe hepatic or renal dysfunction; 5. Morbid obesity (BMI > 30 kg/m²); 6. Allergy or contraindication to propofol and/or opioids; 7. High risk of obstructive sleep apnea; 8. Anticipated difficult airway.

Design outcomes

Primary

MeasureTime frame
Success rate of the anesthesia protocol;

Secondary

MeasureTime frame
Postoperative complications;QoR-15 score;

Countries

China

Contacts

Public ContactJiliang He

Cixi People’s Hospital

hejilianglove@163.com+86 15825550982

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026